| Caveolin-1 and cellular processes | Lifetime | 7 | US 4 | 99.63 |
| Cell Adhesion Molecules Research | Lifetime | 67 | US 41 | 99.69 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 35 | US 14 | 99.48 |
| Erythrocyte Function and Pathophysiology | Lifetime | 44 | US 29 | 99.35 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 38 | US 20 | 99.44 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 142 | US 58 | 99.52 |
| Immune Response and Inflammation | Lifetime | 163 | US 84 | 99.54 |
| Nitric Oxide and Endothelin Effects | Lifetime | 147 | US 74 | 99.24 |
| Neonatal Respiratory Health Research | Lifetime | 280 | US 134 | 99.05 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 133 | US 65 | 99.12 |
| Blood properties and coagulation | Lifetime | 70 | US 41 | 98.88 |
| S100 Proteins and Annexins | Lifetime | 78 | US 43 | 98.80 |
| Protease and Inhibitor Mechanisms | Lifetime | 156 | US 82 | 98.69 |
| NF-κB Signaling Pathways | Lifetime | 112 | US 48 | 98.69 |
| Respiratory Support and Mechanisms | Lifetime | 402 | US 149 | 98.89 |
| Angiogenesis and VEGF in Cancer | Lifetime | 312 | US 144 | 97.99 |
| Ion Channels and Receptors | Lifetime | 108 | US 49 | 97.84 |
| Hemodynamic Monitoring and Therapy | Lifetime | 367 | US 139 | 97.86 |
| Immune cells in cancer | Lifetime | 599 | US 250 | 96.92 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 421 | US 168 | 96.71 |
| Hippo pathway signaling and YAP/TAZ | Lifetime | 196 | US 93 | 96.05 |
| Barrier Structure and Function Studies | Lifetime | 197 | US 92 | 95.72 |
| Inflammasome and immune disorders | Lifetime | 580 | US 158 | 95.17 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 900 | US 364 | 96.11 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 588 | US 305 | 96.23 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 666 | US 267 | 95.86 |
| Kruppel-like factors research | Lifetime | 396 | US 156 | 93.08 |
| Signaling Pathways in Disease | Lifetime | 783 | US 370 | 93.25 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 673 | US 324 | 93.51 |
| Blood transfusion and management | Lifetime | 718 | US 305 | 91.85 |
| Sphingolipid Metabolism and Signaling | Lifetime | 927 | US 344 | 89.22 |
| Erythrocyte Function and Pathophysiology | 2021-2025 | 742 | US 250 | 72.28 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 517 | US 108 | 67.20 |
